These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25131532)

  • 21. Crossreactive αβ T Cell Receptors Are the Predominant Targets of Thymocyte Negative Selection.
    McDonald BD; Bunker JJ; Erickson SA; Oh-Hora M; Bendelac A
    Immunity; 2015 Nov; 43(5):859-69. PubMed ID: 26522985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8αα intraepithelial lymphocytes arise from two main thymic precursors.
    Ruscher R; Kummer RL; Lee YJ; Jameson SC; Hogquist KA
    Nat Immunol; 2017 Jul; 18(7):771-779. PubMed ID: 28530714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of mature T cell populations in the thymus: CD4 or CD8 down-regulation occurs at different stages of thymocyte differentiation.
    Marodon G; Rocha B
    Eur J Immunol; 1994 Jan; 24(1):196-204. PubMed ID: 7912676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human thymocytes become lineage committed at an early postselection CD69+ stage, before the onset of functional maturation.
    Vanhecke D; Verhasselt B; De Smedt M; Leclercq G; Plum J; Vandekerckhove B
    J Immunol; 1997 Dec; 159(12):5973-83. PubMed ID: 9550395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling.
    Savage AK; Constantinides MG; Bendelac A
    J Immunol; 2011 May; 186(10):5801-6. PubMed ID: 21478405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lck activity controls CD4/CD8 T cell lineage commitment.
    Hernández-Hoyos G; Sohn SJ; Rothenberg EV; Alberola-Ila J
    Immunity; 2000 Mar; 12(3):313-22. PubMed ID: 10755618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8/CD4 lineage commitment occurs by an instructional/default process followed by positive selection.
    Benveniste P; Knowles G; Cohen A
    Eur J Immunol; 1996 Feb; 26(2):461-71. PubMed ID: 8617319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of lineage commitment distinct from positive selection.
    Keefe R; Dave V; Allman D; Wiest D; Kappes DJ
    Science; 1999 Nov; 286(5442):1149-53. PubMed ID: 10550051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coreceptor signal strength regulates positive selection but does not determine CD4/CD8 lineage choice in a physiologic in vivo model.
    Erman B; Alag AS; Dahle O; van Laethem F; Sarafova SD; Guinter TI; Sharrow SO; Grinberg A; Love PE; Singer A
    J Immunol; 2006 Nov; 177(10):6613-25. PubMed ID: 17082573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
    Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
    J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal deletion and the fate of autoreactive thymocytes that survive negative selection.
    Pobezinsky LA; Angelov GS; Tai X; Jeurling S; Van Laethem F; Feigenbaum L; Park JH; Singer A
    Nat Immunol; 2012 Apr; 13(6):569-78. PubMed ID: 22544394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes.
    Penninger JM; Sirard C; Mittrücker HW; Chidgey A; Kozieradzki I; Nghiem M; Hakem A; Kimura T; Timms E; Boyd R; Taniguchi T; Matsuyama T; Mak TW
    Immunity; 1997 Aug; 7(2):243-54. PubMed ID: 9285409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Myc controls the development of CD8alphaalpha TCRalphabeta intestinal intraepithelial lymphocytes from thymic precursors by regulating IL-15-dependent survival.
    Jiang W; Ferrero I; Laurenti E; Trumpp A; MacDonald HR
    Blood; 2010 Jun; 115(22):4431-8. PubMed ID: 20308599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice.
    Urban JA; Brugmann W; Winandy S
    J Immunol; 2009 Apr; 182(7):3955-9. PubMed ID: 19299690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
    J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection.
    Yamashita I; Nagata T; Tada T; Nakayama T
    Int Immunol; 1993 Sep; 5(9):1139-50. PubMed ID: 7902130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CD4 coreceptor expression to postselection thymocytes reveals that CD4/CD8 lineage choice is neither error-prone nor stochastic.
    Adoro S; Erman B; Sarafova SD; Van Laethem F; Park JH; Feigenbaum L; Singer A
    J Immunol; 2008 Nov; 181(10):6975-83. PubMed ID: 18981117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.